Stomach bug subtypes may raise cancer risk – study to track 3,000 people

NCT ID NCT06896370

Recruiting now Knowledge-focused Sponsor: Fudan University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study follows 3,000 adults aged 40 and older who carry Helicobacter pylori, a common stomach bug. Researchers want to see if people with certain high-risk subtypes of the bacteria develop stomach cancer more often than those with other subtypes or no infection. Participants will have regular check-ups and stomach exams over 3 to 10 years. No treatment is given—this is purely an observation to better understand cancer risk.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help identify which H. pylori carriers are at highest risk for stomach cancer, enabling targeted screening.
What could go wrong: This is an observational study, not a treatment trial. It only tracks risk and cannot prove cause. Results may take years and may not change current screening guidelines.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GASTRIC (STOMACH) CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

gastric neoplasm Helicobacter pylori infectious disease gastric cancer prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GASTRIC (STOMACH) CANCER HELICOBACTER INFECTION

Contacts and locations

Locations

People's Hospital of Tongling City
RECRUITING

Tongling, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.